HEADER TRANSFERASE 18-AUG-16 5T18 TITLE CRYSTAL STRUCTURE OF BRUTON AGAMMABULINEMIA TYROSINE KINASE COMPLEXED TITLE 2 WITH BMS-986142 AKA (2S)-6-FLUORO-5-[3-(8-FLUORO-1-METHYL-2,4-DIOXO- TITLE 3 1,2,3,4-TETRAHYDROQUINAZOLIN-3-YL)-2-METHYLPHENYL]-2-(2- TITLE 4 HYDROXYPROPAN-2-YL)-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-8-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 6 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID KEYWDS KINASE, BTK, ATK, XLA, PSCTK1, AGMX1, AT, IMD1, MGC126261, MGC126262 KEYWDS 2 BPK, ----, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.K.MUCKELBAUER REVDAT 2 06-MAR-24 5T18 1 REMARK REVDAT 1 08-MAR-17 5T18 0 JRNL AUTH S.H.WATTERSON,G.V.DE LUCCA,Q.SHI,C.M.LANGEVINE,Q.LIU, JRNL AUTH 2 D.G.BATT,M.BEAUDOIN BERTRAND,H.GONG,J.DAI,S.YIP,P.LI,D.SUN, JRNL AUTH 3 D.R.WU,C.WANG,Y.ZHANG,S.C.TRAEGER,M.A.PATTOLI,S.SKALA, JRNL AUTH 4 L.CHENG,M.T.OBERMEIER,R.VICKERY,L.N.DISCENZA,C.J.D'ARIENZO, JRNL AUTH 5 Y.ZHANG,E.HEIMRICH,K.M.GILLOOLY,T.L.TAYLOR,C.PULICICCHIO, JRNL AUTH 6 K.W.MCINTYRE,M.A.GALELLA,A.J.TEBBEN,J.K.MUCKELBAUER,C.CHANG, JRNL AUTH 7 R.RAMPULLA,A.MATHUR,L.SALTER-CID,J.C.BARRISH,P.H.CARTER, JRNL AUTH 8 A.FURA,J.R.BURKE,J.A.TINO JRNL TITL DISCOVERY OF JRNL TITL 2 6-FLUORO-5-(R)-(3-(S)-(8-FLUORO-1-METHYL-2,4-DIOXO-1, JRNL TITL 3 2-DIHYDROQUINAZOLIN-3(4H)-YL)-2-METHYLPHENYL)-2-(S) JRNL TITL 4 -(2-HYDROXYPROPAN-2-YL)-2,3,4, JRNL TITL 5 9-TETRAHYDRO-1H-CARBAZOLE-8-CARBOXAMIDE (BMS-986142): A JRNL TITL 6 REVERSIBLE INHIBITOR OF BRUTON'S TYROSINE KINASE (BTK) JRNL TITL 7 CONFORMATIONALLY CONSTRAINED BY TWO LOCKED ATROPISOMERS. JRNL REF J. MED. CHEM. V. 59 9173 2016 JRNL REFN ISSN 1520-4804 JRNL PMID 27583770 JRNL DOI 10.1021/ACS.JMEDCHEM.6B01088 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 46785 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.203 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 2364 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.000 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.54 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.37 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3189 REMARK 3 BIN R VALUE (WORKING + TEST SET) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3013 REMARK 3 BIN R VALUE (WORKING SET) : 0.2110 REMARK 3 BIN FREE R VALUE : 0.2620 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.52 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 176 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1974 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 147 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.37 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.90 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.44720 REMARK 3 B22 (A**2) : 0.85090 REMARK 3 B33 (A**2) : 0.59630 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.200 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.074 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.073 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.081 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.072 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.949 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3932 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 7064 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 832 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 34 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 644 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3932 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 269 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4375 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.07 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 13.45 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5T18 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 19-AUG-16. REMARK 100 THE DEPOSITION ID IS D_1000223464. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-MAY-13 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46852 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 5.900 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.00 REMARK 200 R MERGE FOR SHELL (I) : 0.62700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG8K + 3% MEPEG5K + 0.2M TRIS REMARK 280 -HCL, PH 7.0, VAPOR DIFFUSION, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.30200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.47750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.87950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.47750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.30200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.87950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 0 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11780 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 393 REMARK 465 MET A 489 REMARK 465 ARG A 490 REMARK 465 HIS A 491 REMARK 465 ARG A 492 REMARK 465 SER A 659 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS A 394 CG ND1 CD2 CE1 NE2 REMARK 470 MET A 395 CG SD CE REMARK 470 LYS A 400 CE NZ REMARK 470 LYS A 406 CG CD CE NZ REMARK 470 GLU A 407 CG CD OE1 OE2 REMARK 470 LYS A 433 CG CD CE NZ REMARK 470 ASP A 440 CG OD1 OD2 REMARK 470 GLU A 441 CD OE1 OE2 REMARK 470 GLU A 444 CG CD OE1 OE2 REMARK 470 LYS A 447 CG CD CE NZ REMARK 470 GLU A 455 CG CD OE1 OE2 REMARK 470 LYS A 466 CG CD CE NZ REMARK 470 GLN A 467 CG CD OE1 NE2 REMARK 470 GLU A 488 CG CD OE1 OE2 REMARK 470 GLN A 494 CG CD OE1 NE2 REMARK 470 GLN A 496 CG CD OE1 NE2 REMARK 470 ASP A 531 CG OD1 OD2 REMARK 470 GLN A 532 CD OE1 NE2 REMARK 470 ARG A 544 CD NE CZ NH1 NH2 REMARK 470 ASP A 548 CG OD1 OD2 REMARK 470 ASP A 549 CG OD1 OD2 REMARK 470 GLU A 550 CG CD OE1 OE2 REMARK 470 TYR A 551 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 THR A 552 OG1 CG2 REMARK 470 SER A 553 OG REMARK 470 SER A 554 OG REMARK 470 VAL A 555 CG1 CG2 REMARK 470 SER A 557 OG REMARK 470 LYS A 558 CG CD CE NZ REMARK 470 LYS A 573 CD CE NZ REMARK 470 LYS A 595 CD CE NZ REMARK 470 ARG A 600 CG CD NE CZ NH1 NH2 REMARK 470 SER A 604 OG REMARK 470 GLU A 608 CG CD OE1 OE2 REMARK 470 HIS A 609 CG ND1 CD2 CE1 NE2 REMARK 470 ILE A 610 CG1 CG2 CD1 REMARK 470 GLN A 612 CG CD OE1 NE2 REMARK 470 LEU A 614 CG CD1 CD2 REMARK 470 GLU A 624 CG CD OE1 OE2 REMARK 470 LYS A 625 CE NZ REMARK 470 GLU A 636 CG CD OE1 OE2 REMARK 470 LYS A 637 CD CE NZ REMARK 470 GLU A 640 CG CD OE1 OE2 REMARK 470 LYS A 645 CE NZ REMARK 470 ASP A 653 CG OD1 OD2 REMARK 470 ASP A 656 CG OD1 OD2 REMARK 470 GLU A 657 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 MET A 450 CG - SD - CE ANGL. DEV. = -10.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 466 43.98 -93.11 REMARK 500 ARG A 520 -17.74 84.17 REMARK 500 ASP A 521 51.38 -148.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 73T A 701 DBREF 5T18 A 396 659 UNP Q06187 BTK_HUMAN 430 693 SEQADV 5T18 GLY A 393 UNP Q06187 EXPRESSION TAG SEQADV 5T18 HIS A 394 UNP Q06187 EXPRESSION TAG SEQADV 5T18 MET A 395 UNP Q06187 EXPRESSION TAG SEQRES 1 A 267 GLY HIS MET GLU ILE ASP PRO LYS ASP LEU THR PHE LEU SEQRES 2 A 267 LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS TYR SEQRES 3 A 267 GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS MET SEQRES 4 A 267 ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE GLU SEQRES 5 A 267 GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS LEU SEQRES 6 A 267 VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO ILE SEQRES 7 A 267 PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU LEU SEQRES 8 A 267 ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR GLN SEQRES 9 A 267 GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA MET SEQRES 10 A 267 GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP LEU SEQRES 11 A 267 ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL VAL SEQRES 12 A 267 LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU ASP SEQRES 13 A 267 ASP GLU TYR THR SER SER VAL GLY SER LYS PHE PRO VAL SEQRES 14 A 267 ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS PHE SEQRES 15 A 267 SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU MET SEQRES 16 A 267 TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU ARG SEQRES 17 A 267 PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN GLY SEQRES 18 A 267 LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS VAL SEQRES 19 A 267 TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA ASP SEQRES 20 A 267 GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE LEU SEQRES 21 A 267 ASP VAL MET ASP GLU GLU SER HET 73T A 701 72 HETNAM 73T 6-FLUORO-5-(R)-(3-(S)-(8-FLUORO-1-METHYL-2,4-DIOXO-1,2- HETNAM 2 73T DIHYDROQUINAZOLIN-3(4H)-YL)-2-METHYLPHENYL)-2-(S)-(2- HETNAM 3 73T HYDROXYPROPAN-2-YL)-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-8- HETNAM 4 73T CARBOXAMIDE HETSYN 73T (2S)-6-FLUORO-5-[3-(8-FLUORO-1-METHYL-2,4-DIOXO-1,4- HETSYN 2 73T DIHYDROQUINAZOLIN-3(2H)-YL)-2-METHYLPHENYL]-2-(2- HETSYN 3 73T HYDROXYPROPAN-2-YL)-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-8- HETSYN 4 73T CARBOXAMIDE FORMUL 2 73T C32 H30 F2 N4 O4 FORMUL 3 HOH *147(H2 O) HELIX 1 AA1 ASP A 398 LEU A 402 5 5 HELIX 2 AA2 SER A 438 ASN A 451 1 14 HELIX 3 AA3 CYS A 481 GLU A 488 1 8 HELIX 4 AA4 GLN A 494 LYS A 515 1 22 HELIX 5 AA5 ALA A 523 ARG A 525 5 3 HELIX 6 AA6 GLY A 541 VAL A 546 5 6 HELIX 7 AA7 ASP A 548 SER A 553 1 6 HELIX 8 AA8 PRO A 560 SER A 564 5 5 HELIX 9 AA9 PRO A 565 SER A 572 1 8 HELIX 10 AB1 SER A 575 SER A 592 1 18 HELIX 11 AB2 THR A 602 GLN A 612 1 11 HELIX 12 AB3 SER A 623 CYS A 633 1 11 HELIX 13 AB4 LYS A 637 ARG A 641 5 5 HELIX 14 AB5 THR A 643 GLU A 658 1 16 SHEET 1 AA1 5 LYS A 406 GLY A 411 0 SHEET 2 AA1 5 GLY A 414 TRP A 421 -1 O GLY A 414 N GLY A 411 SHEET 3 AA1 5 TYR A 425 ILE A 432 -1 O MET A 431 N VAL A 415 SHEET 4 AA1 5 ILE A 470 GLU A 475 -1 O ILE A 472 N LYS A 430 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N TYR A 461 O ILE A 473 SHEET 1 AA2 2 CYS A 527 VAL A 529 0 SHEET 2 AA2 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 CISPEP 1 ARG A 468 PRO A 469 0 0.30 SITE 1 AC1 22 THR A 410 GLY A 411 ARG A 422 GLY A 423 SITE 2 AC1 22 GLN A 424 ALA A 428 LYS A 430 THR A 474 SITE 3 AC1 22 GLU A 475 TYR A 476 MET A 477 ALA A 478 SITE 4 AC1 22 GLY A 480 CYS A 481 ASN A 484 ARG A 525 SITE 5 AC1 22 LEU A 528 HOH A 836 HOH A 853 HOH A 883 SITE 6 AC1 22 HOH A 885 HOH A 900 CRYST1 46.604 69.759 88.955 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021457 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014335 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011242 0.00000